Skip to main content
Top
Published in: Journal of Cancer Survivorship 4/2012

01-12-2012 | Review

Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review

Authors: Talya Salz, Heidi Woo, Tatiana D. Starr, Lina H. Jandorf, Katherine N. DuHamel

Published in: Journal of Cancer Survivorship | Issue 4/2012

Login to get access

Abstract

Purpose

After curative treatment for colorectal cancer (CRC), routine colonoscopies are recommended. We aimed to identify all studies of ethnic disparities in CRC surveillance and examine any association between race/ethnicity and colonoscopy use.

Methods

We conducted a systematic literature review to address the association between race/ethnicity and colonoscopy use among CRC survivors. We searched Medline for relevant articles. Two authors reviewed titles, abstracts, and articles based on pre-determined inclusion/exclusion criteria.

Results

Of the 1,544 titles reviewed, eight studies published since 2001 investigated racial/ethnic disparities in colonoscopy use. Four articles showed a small significant ethnic disparity in the receipt of timely colonoscopy, and the remaining four articles showed a nonsignificant trend in the same direction. The effect did not vary by time of diagnosis or proportion of minorities in each study, though studies with larger samples showed somewhat greater racial/ethnic disparities in colonoscopy use.

Conclusions

We found at least a small disparity in the use of colonoscopy among CRC survivors, suggesting that ethnic disparities continue beyond prevention, detection, and treatment of CRC. It is important to identify areas of unequal care in CRC survivorship and to promote timely surveillance among CRC survivors who belong to racial/ethnic minorities to decrease disparities in mortality.

Implications for Cancer Survivors

CRC survivors who belong to racial/ethnic minorities may be less likely to receive follow-up colonoscopies on time, which could contribue to higher rates of death from CRC among minorities.
Literature
1.
go back to reference National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2003. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2003.
2.
go back to reference National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2005. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2005.
3.
go back to reference National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2006. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Fort Washington: National Comprehensive Cancer Network, Inc.; 2006.
4.
go back to reference Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47(6):807–17.PubMedCrossRef Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47(6):807–17.PubMedCrossRef
5.
go back to reference Desch CE, Benson 3rd AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23(33):8512–9.PubMedCrossRef Desch CE, Benson 3rd AB, Somerfield MR, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005;23(33):8512–9.PubMedCrossRef
6.
go back to reference Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol. 2006;130(6):1865–71.CrossRef Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol. 2006;130(6):1865–71.CrossRef
7.
go back to reference Cooper GS, Kou TD, Reynolds Jr HL. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer. 2008;113(8):2029–37.PubMedCrossRef Cooper GS, Kou TD, Reynolds Jr HL. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer. 2008;113(8):2029–37.PubMedCrossRef
8.
go back to reference Cooper GS, Payes JD. Temporal trends in colorectal procedure use after colorectal cancer resection. Gastrointest Endosc. 2006;64(6):933–40.PubMedCrossRef Cooper GS, Payes JD. Temporal trends in colorectal procedure use after colorectal cancer resection. Gastrointest Endosc. 2006;64(6):933–40.PubMedCrossRef
9.
go back to reference Cooper GS, Yuan Z, Chak A, et al. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer. 1999;85(10):2124–31.PubMedCrossRef Cooper GS, Yuan Z, Chak A, et al. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer. 1999;85(10):2124–31.PubMedCrossRef
10.
go back to reference Ellison GL, Warren JL, Knopf KB, et al. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38(6 Pt 2):1885–903.PubMedCrossRef Ellison GL, Warren JL, Knopf KB, et al. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003;38(6 Pt 2):1885–903.PubMedCrossRef
11.
go back to reference Elston LJ, Cole JC, Ben-Menachem T, et al. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001;39(4):361–72.CrossRef Elston LJ, Cole JC, Ben-Menachem T, et al. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001;39(4):361–72.CrossRef
12.
go back to reference Elston LJ, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43(6):592–9.CrossRef Elston LJ, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005;43(6):592–9.CrossRef
13.
go back to reference Hilsden RJ, Bryant HE, Sutherland LR, et al. A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province. BMC Cancer. 2004;4:14.PubMedCrossRef Hilsden RJ, Bryant HE, Sutherland LR, et al. A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province. BMC Cancer. 2004;4:14.PubMedCrossRef
14.
go back to reference Knopf KB, Warren JL, Feuer EJ, et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc. 2001;54(5):563–71.PubMedCrossRef Knopf KB, Warren JL, Feuer EJ, et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. Gastrointest Endosc. 2001;54(5):563–71.PubMedCrossRef
15.
go back to reference Rolnick S, Hensley Alford S, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;35:96–101.PubMedCrossRef Rolnick S, Hensley Alford S, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;35:96–101.PubMedCrossRef
16.
go back to reference Rulyak SJ, Mandelson MT, Brentnall TA, et al. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc. 2004;59(2):239–47.PubMedCrossRef Rulyak SJ, Mandelson MT, Brentnall TA, et al. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc. 2004;59(2):239–47.PubMedCrossRef
17.
go back to reference Salz T, Weinberger M, Ayanian JZ, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res. 2010;10:256.PubMedCrossRef Salz T, Weinberger M, Ayanian JZ, et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States. BMC Health Serv Res. 2010;10:256.PubMedCrossRef
18.
go back to reference Ries LAG, Horner MJ, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK, editors. SEER Cancer Statistics Review 1975–2006. Bethesda, MD: National Cancer Institute; 2009. Ries LAG, Horner MJ, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK, editors. SEER Cancer Statistics Review 1975–2006. Bethesda, MD: National Cancer Institute; 2009.
19.
go back to reference Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.PubMedCrossRef Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.PubMedCrossRef
20.
go back to reference Doubeni CA, Laiyemo AO, Klabunde CN, et al. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med. 2010;38(2):184–91.PubMedCrossRef Doubeni CA, Laiyemo AO, Klabunde CN, et al. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med. 2010;38(2):184–91.PubMedCrossRef
21.
go back to reference Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996;34(9):970–84.PubMedCrossRef Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996;34(9):970–84.PubMedCrossRef
22.
go back to reference Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCrossRef Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCrossRef
23.
go back to reference Cooper GS, Yuan Z, Chak A, et al. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. Gastrointest Endosc. 2000;52(1):33–8.PubMedCrossRef Cooper GS, Yuan Z, Chak A, et al. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. Gastrointest Endosc. 2000;52(1):33–8.PubMedCrossRef
24.
go back to reference Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004;99(8):1544–50.PubMedCrossRef Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004;99(8):1544–50.PubMedCrossRef
25.
go back to reference Cooper GS, Yuan Z, Landefeld CS, et al. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996;86(4):582–6.PubMedCrossRef Cooper GS, Yuan Z, Landefeld CS, et al. Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health. 1996;86(4):582–6.PubMedCrossRef
26.
go back to reference Hao Y, Landrine H, Jemal A, et al. Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Community Health. 2011;65(3):211–7.PubMedCrossRef Hao Y, Landrine H, Jemal A, et al. Race, neighbourhood characteristics and disparities in chemotherapy for colorectal cancer. J Epidemiol Community Health. 2011;65(3):211–7.PubMedCrossRef
27.
go back to reference Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87(22):1686–93.PubMedCrossRef Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst. 1995;87(22):1686–93.PubMedCrossRef
28.
go back to reference Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.PubMedCrossRef Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.PubMedCrossRef
29.
go back to reference Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4(3):277–94.PubMedCrossRef Green CR, Anderson KO, Baker TA, et al. The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med. 2003;4(3):277–94.PubMedCrossRef
30.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in translation. Washington, D.C: Institute of Medicine and National Research Council; 2005. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in translation. Washington, D.C: Institute of Medicine and National Research Council; 2005.
31.
go back to reference Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.PubMedCrossRef Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer. 2004;101(8):1712–9.PubMedCrossRef
32.
go back to reference Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv. 2009;3(1):43–58.PubMedCrossRef Findley PA, Sambamoorthi U. Preventive health services and lifestyle practices in cancer survivors: a population health investigation. J Cancer Surviv. 2009;3(1):43–58.PubMedCrossRef
33.
go back to reference Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, D.C: Institute of Medicine and National Research Council; 2005. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, D.C: Institute of Medicine and National Research Council; 2005.
34.
go back to reference Salz T, Oeffinger KC, McCabe MS, et al. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62(2):101–17.CrossRef Salz T, Oeffinger KC, McCabe MS, et al. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62(2):101–17.CrossRef
35.
go back to reference Burg MA, Lopez ED, Dailey A, et al. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 Suppl 2:S467–71.PubMedCrossRef Burg MA, Lopez ED, Dailey A, et al. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 Suppl 2:S467–71.PubMedCrossRef
Metadata
Title
Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review
Authors
Talya Salz
Heidi Woo
Tatiana D. Starr
Lina H. Jandorf
Katherine N. DuHamel
Publication date
01-12-2012
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2012
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-012-0231-0

Other articles of this Issue 4/2012

Journal of Cancer Survivorship 4/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine